| Filed On | Filing |
|---|---|
| 16 Nov 2026 | SCHEDULE 13G/A |
| 09 Nov 2026 | SCHEDULE 13G |
| 03 Nov 2026 | QUARTERLY REPORT |
| 06 Oct 2026 | SCHEDULE 13G/A |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 13 Aug 2026 | SCHEDULE 13G |
| 12 Aug 2026 | SCHEDULE 13G/A |
| 07 Aug 2026 | QUARTERLY REPORT |
| 03 Aug 2026 | CURRENT REPORT |
| 03 Aug 2026 |
8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
Business Combination Agreement, dated as of August 3, 2026 (the “Signing Date”) (this “Agreement”), by and among Startech Group Inc., a Delaware corporation (the “Company”), Newbridge Acquisition Limited, a British Virgin Islands busines... |
| 15 May 2026 | SCHEDULE 13G |
| 14 May 2026 | SCHEDULE 13G |
| 14 May 2026 | SCHEDULE 13G |
| 11 May 2026 | QUARTERLY REPORT |
| 20 Apr 2026 | SCHEDULE 13G |
| 23 Mar 2026 | ANNUAL REPORT |
| 18 Mar 2026 |
8-K: Other Events
Newbridge Acquisition Limited Announces the Separate Trading of its Class A Ordinary Shares and Rights Commencing March 23, 2026 |
| 02 Mar 2026 |
8-K: Other Events
On February 27, 2026, Newbridge Acquisition Limited (the “Company”) and Starcoin Group Limited, (formerly known as Innovative Pharmaceutical Biotech Limited), a company incorporated in the Cayman Islands and continued in Bermuda with lim... |
| 17 Feb 2026 | SCHEDULE 13G |
| 17 Feb 2026 | SCHEDULE 13G |
Loading...